Our results showed that a low concentration of thalidomide 0.1 μg/ml, but not pomalidomide, could inhibit the expression of bFGF through IRES upon AIG, indicating a non-cytotoxic mechanism for the inhibition of cancer stem-like cells. Here, FGF2 is linked to cancer.